Mass spectrometry-based proteomic approaches for discovery of HIV-host interactions

被引:15
|
作者
Luo, Yang [1 ]
Muesing, Mark A. [1 ]
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
affinity purification; HIV-1; MS-based proteomics; post-translational modification; quantitative MS; virus-host interactions; AFFINITY PURIFICATION; CELLULAR-PROTEINS; INNATE IMMUNITY; CBF-BETA; INFECTION; IDENTIFICATION; EXPRESSION; INTEGRASE; GENE; REVEALS;
D O I
10.2217/FVL.14.86
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A molecular understanding of viral infection requires a multi-disciplinary approach. Mass spectrometry has emerged as an indispensable tool to investigate the complex and dynamic interactions between HIV-1 and its host. It has been employed to study protein associations, changes in protein abundance and post-translational modifications occurring after viral infection. Here, we review and provide examples of mass spectrometry-based proteomic approaches currently used to explore virus-host interaction. Efforts in this area are certain to accelerate the discovery of the unique molecular strategies utilized by the virus to commandeer the cell as well as mechanisms of host defense.
引用
收藏
页码:979 / 992
页数:14
相关论文
共 50 条
  • [21] HIV-host interactions: a map of viral perturbation of the host system
    Pinney, John W.
    Dickerson, Jonathan E.
    Fu, William
    Sanders-Beer, Brigitte E.
    Ptak, Roger G.
    Robertson, David L.
    AIDS, 2009, 23 (05) : 549 - 554
  • [22] HIV-Host Interactions: Implications for Vaccine Design
    Haynes, Barton F.
    Shaw, George M.
    Korber, Bette
    Kelsoe, Garnett
    Sodroski, Joseph
    Hahn, Beatrice H.
    Borrow, Persephone
    McMichael, Andrew J.
    CELL HOST & MICROBE, 2016, 19 (03) : 292 - 303
  • [23] The importance of mass spectrometry-based untargeted metabolomic approaches for biomarker discovery in lysosomal diseases
    Auray-Blais, Christiane
    Boutin, Michel
    Kelkel, Marcel Andre
    Menkovic, Iskren
    Martineau, Tristan
    Lavoie, Pamela
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S17 - S17
  • [24] Proteome discovery pipeline for mass spectrometry-based proteomics
    Erik Gough
    Cheolhwan Oh
    Jing He
    Catherine P Riley
    Charles R Buck
    Xiang Zhang
    BMC Bioinformatics, 9
  • [25] Mass Spectrometry-Based Proteomics in Preclinical Drug Discovery
    Schirle, Markus
    Bantscheff, Marcus
    Kuster, Bernhard
    CHEMISTRY & BIOLOGY, 2012, 19 (01): : 72 - 84
  • [26] Visualizing and quantifying HIV-host interactions with fluorescence microscopy
    Hendrix, Jelle
    Debyser, Zeger
    Hofkens, Johan
    Engelborghs, Yves
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2011, 40 : 48 - 48
  • [27] Biomarker discovery in mass spectrometry-based urinary proteomics
    Thomas, Samuel
    Hao, Ling
    Ricke, William A.
    Li, Lingjun
    PROTEOMICS CLINICAL APPLICATIONS, 2016, 10 (04) : 358 - 370
  • [28] Advances in mass spectrometry-based clinical biomarker discovery
    Crutchfield, Christopher A.
    Thomas, Stefani N.
    Sokoll, Lori J.
    Chan, Daniel W.
    CLINICAL PROTEOMICS, 2016, 13
  • [29] HIV-host interactions: research challenges and future directions
    Alcami, J.
    FEBS JOURNAL, 2012, 279 : 42 - 42
  • [30] Mass Spectrometry-based Quantitative Analysis and Biomarker Discovery
    Suzuki, Naoto
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (09): : 1305 - 1309